Francesca Barei
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Letter: Real-Life Improvement in Quality of Life With Delgocitinib in Chronic Hand Eczema.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: June 19, 2026
Patch test sensitization and permanent tattoos: epidemiological data from two referral centers.
Journal: European annals of allergy and clinical immunology
Published: June 10, 2026
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).
Journal: Dermatology and therapy
Published: March 17, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.
Journal: Dermatology and therapy
Published: March 11, 2026
Letter: Tralokinumab Dose Spacing in Moderate-to-Severe Atopic Dermatitis: A Real-World Case Series.
Letter: Tralokinumab Dose Spacing in Moderate-to-Severe Atopic Dermatitis: A Real-World Case Series.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: February 17, 2026
A 52-Week Retrospective Italian Study of Flare Characteristics in Adult Atopic Dermatitis Patients Receiving JAK Inhibitors.
Journal: International journal of dermatology
Published: December 18, 2025
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).
Journal: Acta dermato-venereologica
Published: November 16, 2025
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: November 07, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.
Journal: Dermatology and therapy
Published: August 12, 2025
Patch Testing Under Biologics: Six Cases From a Tertiary Centre.
Journal: Contact dermatitis
Published: August 04, 2025
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort Study.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: July 31, 2025
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study.
Journal: Antibodies (Basel, Switzerland)
Published: July 24, 2025
Last Updated: 09/26/2026